
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Syra Health Corp. Class A Common Stock (SYRA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: SYRA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $0
1 Year Target Price $0
0 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -44.59% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.19M USD | Price to earnings Ratio - | 1Y Target Price 1.8 |
Price to earnings Ratio - | 1Y Target Price 1.8 | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 |
52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.43% | Operating Margin (TTM) -25.48% |
Management Effectiveness
Return on Assets (TTM) -42.21% | Return on Equity (TTM) -94.29% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -1166862 | Price to Sales(TTM) 0.15 |
Enterprise Value -1166862 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.5 | Enterprise Value to EBITDA - | Shares Outstanding 11339200 | Shares Floating 8861182 |
Shares Outstanding 11339200 | Shares Floating 8861182 | ||
Percent Insiders 13.48 | Percent Institutions 1.49 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Syra Health Corp. Class A Common Stock
Company Overview
History and Background
Syra Health Corp. is a healthcare company that aims to improve healthcare access and outcomes through technology-enabled solutions. Founded in 2020, Syra Health has expanded to focus on behavioral and mental health support, telehealth, and innovative technologies to address gaps in the healthcare system.
Core Business Areas
- Behavioral and Mental Health Services: Provides mental health support, therapy, and behavioral health services to patients remotely and in person.
- Telehealth Solutions: Offers telehealth platforms and services enabling virtual consultations, remote monitoring, and digital health programs.
- Healthcare Technology Consulting: Provides healthcare organizations consulting services focused on strategy, process improvement, and technology deployment.
Leadership and Structure
The leadership team is comprised of experienced healthcare executives and technology experts. The company operates with a functional organizational structure, with departments dedicated to technology, clinical services, and business development.
Top Products and Market Share
Key Offerings
- Virtual Behavioral Health Platform: A telehealth platform facilitating online therapy and mental health support. Market share is growing but still relatively small in the fragmented telehealth market. Key competitors include Teladoc Health (TDOC) and Amwell (AMWL).
- Healthcare Technology Consulting Services: Consulting services providing strategic guidance to healthcare organizations on IT implementation and optimization. Competitors include Accenture (ACN) and Deloitte.
Market Dynamics
Industry Overview
The healthcare industry is undergoing significant transformation, with increasing adoption of telehealth, digital health solutions, and emphasis on mental healthcare. The market is highly competitive and driven by technological advancements, regulatory changes, and increasing demand for healthcare services.
Positioning
Syra Health is positioned as a healthcare technology provider focusing on improving access to care through telehealth and mental health solutions. It aims to differentiate itself through integrated technology platforms and personalized healthcare services.
Total Addressable Market (TAM)
The TAM for telehealth and behavioral health services is estimated at hundreds of billions of dollars. Syra Health Corp. Class A Common Stock is positioned to capture a growing share of this market through its targeted offerings and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Focus on telehealth and mental healthcare
- Technology-driven platform
- Experienced management team
Weaknesses
- Limited brand recognition
- Smaller market share compared to competitors
- Dependence on technology integration
Opportunities
- Expanding telehealth adoption
- Increasing demand for mental health services
- Strategic partnerships with healthcare organizations
Threats
- Regulatory changes
- Increased competition
- Data security and privacy risks
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- CVS
Competitive Landscape
Syra Health Corp. faces intense competition from established telehealth providers and large healthcare organizations. Its advantages include its specialized focus on mental health and integrated technology platform, but it needs to build brand recognition and scale its operations to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Data to perform this is not readily available for a young company like Syra Health Corp.
Future Projections: Analyst projections suggest strong growth potential driven by increasing adoption of telehealth and mental health services.
Recent Initiatives: Recent initiatives include expanding telehealth platform features, establishing partnerships with healthcare providers, and launching new mental health programs.
Summary
Syra Health Corp. is a relatively young company focused on leveraging technology to improve healthcare access, particularly in the areas of telehealth and mental health services. The company is strategically positioned to benefit from the increasing adoption of telehealth and growing demand for mental health support. However, it faces significant competition from larger, more established players and needs to focus on scaling its operations and building brand awareness. The financial performance and market data is still developing as the company matures.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Market Research Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share estimates are approximate and may vary. Financial data may be limited for a young company.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Syra Health Corp. Class A Common Stock
Exchange NASDAQ | Headquaters Carmel, IN, United States | ||
IPO Launch date 2023-09-29 | Interim CEO, CFO, COO & Director Ms. Priya Prasad | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 57 | Website https://www.syrahealth.com |
Full time employees 57 | Website https://www.syrahealth.com |
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.